Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Prescient Therapeutics, Ltd.
City of Hope Medical Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
University College, London
4SC AG
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC
University of Nebraska
Genmab
Stanford University
Genmab
Thomas Jefferson University
European Organisation for Research and Treatment of Cancer - EORTC
Novartis
Rochester General Hospital
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Chicago
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Northwestern University
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
Neumedicines Inc.
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Stanford University
Alliance for Clinical Trials in Oncology
Mayo Clinic
Angimmune LLC
Rutgers, The State University of New Jersey
Vanderbilt University
Valerio Therapeutics
National Cancer Institute (NCI)
FDA Office of Orphan Products Development